About Amolab
Amolab is a company based in Lecce (Italy) founded in 2011. Amolab offers products and services including SensUS Lung, SensUS Touch, Amolab Suite (modulo Lung), LaborSIM, and ProgSim. Amolab operates in a competitive market with competitors including Celmatix, Metabolomic Diagnostics, Confer Health, LIA Diagnostics and adyn, among others.
- Latest Funding Round$60.63K (USD), Grant
Apr 2018
- InvestorsEuropean Union
& 1 more
Products & Services of Amolab
Amolab offers a comprehensive portfolio of products and services, including SensUS Lung, SensUS Touch, Amolab Suite (modulo Lung), LaborSIM, and ProgSim.
Portable ecographic tool for lung monitoring in pneumology.
Device for tracking labor and fetal progress accurately.
Integrated software for enhanced lung diagnostic imaging.
Training software for medical labor and delivery scenarios.
Program for simulating obstetric procedures and diagnostics.
Apps and channels of Amolab
its YouTube channel Amolab Srl has 28 subscribers and 28 videos.
Videos from Amolab
The most watched videos on Amolab's YouTube channel, Amolab Srl (28 subscribers). Click a video to play it here.
More on Amolab Srl.
Funding Insights of Amolab
- Total Rounds 2
- Last Round Grant — $60,634
- First Round $60,054
(Jan 2018)
- Investors Count 2
All 2 funding rounds of Amolab with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2018 | $60,634 | Grant | – | – | |
| Jan 2018 | $60,054 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Amolab
Amolab has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Amolab
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Amolab
3 dated milestones of Amolab across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Amolab is founded.
- Funding First funding round of $60K.
- Funding Latest funding round, Grant, of $61K.
Competitors of Amolab
Amolab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celmatix, Metabolomic Diagnostics, Confer Health, LIA Diagnostics and adyn, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celmatix.com | 2009 | New York, United States | $24.89M | 27 | Fertility decisions are optimized using data analytics and genomics. | |
| metabolomicdiagnostics.com | 2011 | Cork, Ireland | $3.89M | – | Diagnostics and prognostics for maternal health are developed using metabolomics. | |
| confer.health | 2015 | Boston, United States | $9.5M | – | Clinical-grade diagnostic tests for home use are developed. | |
| liadiagnostics.com | 2015 | Philadelphia, United States | $4.22M | – | Disposable paper pregnancy test kits | |
| adyn.com | 2019 | Seattle, United States | $2.65M | – | Provider of DNA and hormone analysis based birth control optimization kits | |
| jabrehoo.com | 2011 | Beijing, China | $14.35M | – | Next-generation sequencing services for assisted reproduction are integrated. | |
| bludiagnostics.com | 2015 | Madison, United States | $1.15M | – | Saliva-based fertility tests for women | |
| milulabs.com | 2018 | New York, United States | – | – | Exosome-based diagnostic products for health screening are offered. |
Detailed competitors of Amolab
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Amolab
The website of Amolab (amolab.it) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 100.1% vs previous month
Similar companies to Amolab
10 companies that operate in the same segment as Amolab (Women's Health & Fertility), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Silicone-filled breast and body shaping implants are designed and manufactured. | 2010 | Alajuela, Alajuela, Costa Rica | USD 121 M | USD 211.08 M | 1,020 | |
Immunotherapeutics for cancer and other diseases are developed. | 2008 | Mainz, Rhineland-palatinate, Germany | USD 805.99 M | USD 3.24 B | 6,770 | |
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 124.07 M | USD 19.59 M | – | |
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | – | 47 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Platform for breast ultrasound imaging | 2010 | Plymouth, Massachusetts, United States | USD 136.54 M | – | – | |
Silicone breast implants are developed for reconstruction and aesthetic surgery. | 2007 | Dublin, Ireland | USD 232.81 M | – | – | |
A minimally invasive ablation system for uterine fibroids is developed. | 2005 | Redwood City, California, United States | USD 282.54 M | – | 92 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Amolab
Amolab was founded in 2011 and raised its 1st funding round 7 years after it was founded.
Amolab is headquartered in Lecce, Italy. It is registered at Lecce, Puglia, Italy.
AMOLAB is engaged in the development, manufacturing, and marketing of ultrasonic medical devices for non-invasive monitoring and diagnostic support of labor progression. Its flagship product SensUS Touch is a next-gen quantitative ultrasound (US) ultraportable tablet imaging device that allows monitoring of all pregnancy phases, from conception to childbirth labor. The other product SensUS View is an Echo Color Doppler systems based on panel PC with touch screen monitor and Amolab Suite and MultiWave software. It is a spin-off of the National Research Council in Lecce (Italy).
Amolab's top competitors include Celmatix, Metabolomic Diagnostics and LIA Diagnostics.
Amolab offers SensUS Lung, SensUS Touch, Amolab Suite (modulo Lung), LaborSIM, and ProgSim.
Amolab has 2 investors. Key investors include European Union, and EIC Fund.